Beta-blockers before coronary artery bypass grafting surgery not associated with better outcomes

June 16, 2014

Use of beta (β)-blockers in patients who have not had a recent heart attack but were undergoing nonemergency coronary artery bypass grafting (CABG) surgery was not associated with better outcomes.

The use of preoperative β-blockers has been associated with a reduction in perioperative mortality for patients undergoing CABG in previous observational studies. Preoperative β-blocker therapy is a national quality standard.

The authors conducted a retrospective analysis of the Society of Thoracic Surgeons National Adult Cardiac database of U.S. hospitals performing from 2008 to 2012. The study included 506,110 patients undergoing nonemergency CABG surgery who had not had a heart attack in the previous 21 days or any other high-risk symptoms.

Of the 506,110 patients, 86.2 percent received preoperative β-blockers within 24 hours of surgery. The authors found no difference between patients who did and did not receive preoperative β-blockers in rates of death due to the operation, stroke, prolonged ventilation, any reoperation, renal failure and deep sternal wound infection. Patients who received preoperative β-blockers did have higher rates of new-onset atrial fibrillation than patients who did not.

"β-blockers are an important and effective tool in the care of patients undergoing cardiac surgery in specific clinical scenarios. However, the empirical use of β-blockers as recommended by the National Quality Forum (without physiologic goals i.e., adequate clinical drug levels) in all before CABG may not improve outcomes. A with careful attention to adequate dosing and specific drug type may help to answer this question," William Brinkman, M.D., of the Cardiopulmonary Research Science and Technology Institute, Dallas, and colleagues said in their JAMA Internal Medicine article.

Explore further: Beta-blockers before surgery appear associated with lower risk of heart-related events

More information: JAMA Intern Med. Published online June 16, 2014. DOI: 10.1001/jamainternmed.2014.2356
JAMA Intern Med. Published online June 16, 2014. DOI: 10.1001/jamainternmed.2014.155

Related Stories

Beta-blockers before surgery appear associated with lower risk of heart-related events

November 18, 2013
Giving beta-blocker medication to patients with heart disease undergoing noncardiac surgery appears to be associated with a lower risk of death and major adverse cardiovascular events (MACE) 30 days after surgery in patients ...

Beta blockers and perioperative care: EHJ addresses controversy

February 7, 2014
Since the end of 2011 when the scientific work of Professor Don Poldermans was first scrutinized there has been controversy in the medical world about the use of beta blockers in perioperative care.

Hospital quality adds to disparities in cardiac surgery

January 13, 2014
(HealthDay)—Hospital quality contributes to the racial disparities in outcomes after coronary artery bypass graft (CABG) surgery, according to research published online on Jan. 8 in JAMA Surgery.

Post-op kidney risk reduced in 'off-pump' patients

June 4, 2014
(Medical Xpress)—Among patients undergoing coronary artery bypass graft (CABG) surgery, those who were not put on a heart-lung machine (off-pump) had a reduced risk of postoperative kidney injury compared to patients who ...

Beta-blockers have no impact on cocaine-related chest pain

June 3, 2014
(HealthDay)—For patients with cocaine-associated chest pain, there are no differences in outcome for those treated with or without β-blockers, according to a study published in the June 1 issue of The American Journal ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.